Listen to Gynecologic Oncology
Ein Podcast von Gynecologic Oncology

Kategorien:
50 Folgen
-
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer
Vom: 27.3.2025 -
Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study
Vom: 3.3.2025 -
Clinical trials: Panacea or pitfall
Vom: 27.1.2025 -
FOLR1 status: Landscape beyond high grade serous ovarian cancer
Vom: 30.12.2024 -
Benefits of hormonal therapy for low grade serous ovarian cancer
Vom: 30.12.2024 -
Implementation and impact of a financial navigation program in gynecologic oncology
Vom: 23.10.2024 -
LVSI in Stage 1 Endometrial Cancer
Vom: 25.9.2024 -
Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer
Vom: 2.9.2024 -
Shifting trends and sicker patients - the future of gynecologic cancer
Vom: 12.7.2024 -
2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement
Vom: 8.7.2024 -
Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?
Vom: 15.4.2024 -
Editor's Choice: Caring for the Caregiver
Vom: 4.4.2024 -
Editor’s Choice: Lunchbox Trial
Vom: 29.2.2024 -
Editor’s Choice: Engagement with ERAS patients leads to improved outcomes
Vom: 29.1.2024 -
October 2023 Editor’s Choice: OS updates for Imagyn50
Vom: 17.11.2023 -
September 2023 Editor’s Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?
Vom: 27.10.2023 -
August 2023 Editor’s Choice: What is your center doing to improve genetic testing following abnormal MMR results in endometrial cancer?
Vom: 28.9.2023 -
July 2023 Editor’s Choice: The evolution of patient-centered endometrial cancer detection: testing tompon-based collection for methylated DNA markers
Vom: 16.8.2023 -
TKI Toxicities: A Society of Gynecologic Oncology Podcast
Vom: 10.7.2023 -
June 2023 Editor's Choice: ERAS Society Updates: What Every Gyn Oncologist Should Know
Vom: 1.7.2023
Listen to the latest news from the experts in your field.